Back
Sturm Ruger & 10K Form
Sell
39
RGR
Sturm Ruger &
Last Price:
41.78
Seasonality Move:
3.16%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-07 | 10Q | RGR/Sturm Ruger & Quarterly |
2023-11-01 | 10Q | RGR/Sturm Ruger & Quarterly |
2023-08-02 | 10Q | RGR/Sturm Ruger & Quarterly |
2023-05-03 | 10Q | RGR/Sturm Ruger & Quarterly |
2022-11-02 | 10Q | RGR/Sturm Ruger & Quarterly |
2022-08-03 | 10Q | RGR/Sturm Ruger & Quarterly |
Receive RGR News And Ratings
See the #1 stock for the next 7 days that we like better than RGR
RGR Financial Statistics
Sales & Book Value
Annual Sales: | $543.77M |
---|---|
Cash Flow: | $2.62M |
Price / Cash Flow: | 23.83 |
Annual Sales: | $18.76 |
Price / Book: | 2.23 |
Profitability
EPS (TTM): | 1.73000 |
---|---|
Net Income (TTM): | $30.34M |
Gross Margin: | $133.62M |
Return on Equity: | 9.28% |
Return on Assets: | 7.84% |
Sturm Ruger & Earnings Forecast
Key Sturm Ruger & Financial Ratios
- The Gross Profit Margin over the past 40 years for RGR is 24.57%.
- The Selling, General & Administrative Expenses for RGR have been equal to 15.00% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 0.43% of Operating Income.
- The Net Earning history of RGR is 8.87% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 22 years.
Sturm Ruger & Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Leisure Products |
Sector: | Consumer Discretionary |
Current Symbol: | RGR |
CUSIP: | 864159 |
Website: | ruger.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 4.5 |
Quick Ratio: | 2.84 |
Price-to-Earnings
Trailing P/E Ratio: | 15.41 |
---|---|
Forward P/E Ratio: | 16.51 |
RGR Technical Analysis vs Fundamental Analysis
Sell
39
Sturm Ruger & (RGR)
is a Sell
Is Sturm Ruger & a Buy or a Sell?
-
Sturm Ruger & stock is rated a Sell
The current Sturm Ruger & [RGR] share price is $41.76. The Score for RGR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.